Dr. Reddy's Laboratories Limited — Important, 29-10-2025: Updates
29-10-2025 | 05:49 pm
29-10-2025 | 05:49 pm
Dr. Reddy's received an objection from Canada's drug authority for its Semaglutide Injection application, seeking further information. The company expressed confidence in its product quality and will submit a prompt response, remaining committed to timely market availability in Canada.
No comments yet. Be the first to comment!
